Treatment of ITP With Rituximab and / or Accutane

• Status: Unknown status
• Trial end date: 2018-12-01

Summary

a prospective, multicenter, randomized, open-label, Phase II, two arms interventional trial performed in 5 departments of hematology in China

• Phase: Phase 2

Details

• Lead Sponsor: Peking University People's Hospital
• Collaborator: Beijing Hospital
• Treatments: Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate; Rituximab